Author

Genesis Snyder

Nationwide Children's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:proteomics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Colin T. MaguireiD· 2 shared Meisam Naeimi KararoudiiD· 2 shared Noushin SaljoughianiD· 2 shared Yasemin SezginiD· 2 shared Afrooz RashnonejadiD· 1 shared Alexia K. MartiniD· 1 shared Ali A. AshkariD· 1 shared Allison M. BradburyiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Colin T. MaguireORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Off-the-shelf allogeneic polyclonal CD38KO/CD38-CAR γδT cells for the treatment of T cell malignancies

Genesis Snyder, Alexia K. Martin, Yasemin Sezgin, Colin T. Maguire, Branden S. Moriarity, Beau R. Webber, Erin Cross, Marcelo de Souza Fernandes Pereira, Noushin Saljoughian, Ana L. Portillo, Misaal Mehboob, Justin M. Lyberger, Kevin A. Cassady, Ali A. Ashkar, Gregory K. Behbehani, , Meisam Naeimi Kararoudi

This paper develops CD38KO/CD38-CAR γδT cells for T cell malignancies, showing they effectively target T-ALL without causing fratricide or GvHD.

bioRxiv · Aug 30, 2025 · PreprintImmunology

REMEDY: REpair of heterozygous Mutations independent of Exogenous Donor template with high efficiency using allele specific CRISPR targeting and HDR enhancers

Yasemin Sezgin, Genesis Snyder, Noushin Saljoughian, Colin T. Maguire, Ebru Erzurumluoğlu Gökalp, Devi Jaganathan, Eleonora Silvana D'Ambrosio, Burçak Özeş, Gregory L. Wheeler, Ben Kelly, Mark E. Hester, Zarife Sahenk, Sriram Vaidyanathan, Afrooz Rashnonejad, Jerry R. Mendell, , Meisam Naeimi Kararoudi

REMEDY enables efficient repair of heterozygous mutations in human and mouse cells without exogenous donor DNA by using CRISPR-induced DSBs and HDR enhancers.

bioRxiv · May 29, 2025 · PreprintGenetics